Sunitinib in Metastatic Renal Cell Carcinoma: The Pharmacological Basis of the Alternative 2/1 Schedule

• Antonello Di Paolo,
• Sergio Bracarda,
• Elena Arrigoni,
• Romano Danesi

Affiliations

Antonello Di Paolo

Department of Clinical and Experimental Medicine, University of PisaPisa, Italy

Sergio Bracarda

Medical Oncology, Ospedale San Donato USL8, Istituto Toscano TumoriArezzo, Italy

Elena Arrigoni

Department of Clinical and Experimental Medicine, University of PisaPisa, Italy

Romano Danesi

Department of Clinical and Experimental Medicine, University of PisaPisa, Italy